Literature DB >> 23979692

Pericentrin expression in Down's syndrome.

Michele Salemi1, Concetta Barone, Carmelo Romano, Roberto Salluzzo, Filippo Caraci, Rita Anna Cantarella, Maria Grazia Salluzzo, Filippo Drago, Corrado Romano, Paolo Bosco.   

Abstract

Down's syndrome (DS) is the most frequent genetic cause of intellectual disability and is a chromosomal abnormality of chromosome 21 trisomy. The pericentrin gene (PCNT) has sequenced in 21q22.3 inside of the minimal critical region for Down's syndrome. Alterations of PCNT gene are associated with dwarfism, cardiomyopathy and other pathologies. In this study, we have evaluated the possible differential expression of PCNT mRNA, by qRT-PCR, in peripheral blood leukocytes of DS subjects compared with the normal population. In the present case-control study, PCNT gene expression was increased by 72.72% in 16 out 22 DS samples compared with normal subjects. Our data suggest that changes in the expression levels of PCNT in DS subjects may be involved into the molecular mechanism of Down's syndrome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23979692     DOI: 10.1007/s10072-013-1529-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  11 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  SPAG5 mRNA is over-expressed in peripheral blood leukocytes of patients with Down's syndrome and cryptorchidism.

Authors:  Michele Salemi; Giusi A Longo; Sandro La Vignera; Corrado Romano; Rosita A Condorelli; Carmelo Romano; Paolo Bosco; Enzo Vicari; Aldo E Calogero
Journal:  Neurol Sci       Date:  2012-07-08       Impact factor: 3.307

Review 3.  Centrosome control of the cell cycle.

Authors:  Stephen Doxsey; Wendy Zimmerman; Keith Mikule
Journal:  Trends Cell Biol       Date:  2005-06       Impact factor: 20.808

4.  Gene expression profiling and qRT-PCR expression of RRP1B, PCNT, KIF21A and ADRB2 in leucocytes of Down's syndrome subjects.

Authors:  Michele Salemi; Concetta Barone; Corrado Romano; Francesca Zolezzi; Carmelo Romano; Cataldo Scavuzzo; Roberto Salluzzo; Francesco Scillato; Maria Signorelli; Dimos Kapetis; Maria Grazia Salluzzo; Paolo Bosco
Journal:  J Genet       Date:  2012-03-13       Impact factor: 1.166

5.  Identification of a human centrosomal calmodulin-binding protein that shares homology with pericentrin.

Authors:  M R Flory; M J Moser; R J Monnat; T N Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

6.  Defective thymic progenitor development and mature T-cell responses in a mouse model for Down syndrome.

Authors:  Laureanne P E Lorenzo; Kristen E Shatynski; Sarah Clark; Paul J Yarowsky; Mark S Williams
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

Review 7.  Down syndrome: advances in molecular biology and the neurosciences.

Authors:  G T Capone
Journal:  J Dev Behav Pediatr       Date:  2001-02       Impact factor: 2.225

8.  Mitosis-specific anchoring of gamma tubulin complexes by pericentrin controls spindle organization and mitotic entry.

Authors:  Wendy C Zimmerman; James Sillibourne; Jack Rosa; Stephen J Doxsey
Journal:  Mol Biol Cell       Date:  2004-05-14       Impact factor: 4.138

9.  KIF21A mRNA expression in patients with Down syndrome.

Authors:  Michele Salemi; Concetta Barone; Carmelo Romano; Federico Ridolfo; Cataldo Scavuzzo; Rita Anna Cantarella; Maria Grazia Salluzzo; Aldo E Calogero; Corrado Romano; Paolo Bosco
Journal:  Neurol Sci       Date:  2012-09-12       Impact factor: 3.307

Review 10.  Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis.

Authors:  Donna M Wilcock; W Sue T Griffin
Journal:  J Neuroinflammation       Date:  2013-07-16       Impact factor: 8.322

View more
  1 in total

1.  Killer-specific secretory (Ksp37) gene expression in subjects with Down's syndrome.

Authors:  Michele Salemi; Concetta Barone; Maria Concetta Morale; Salvatore Caniglia; Carmelo Romano; Maria Grazia Salluzzo; Rosanna G Galati Rando; Alda Ragalmuto; Paolo Bosco; Corrado Romano
Journal:  Neurol Sci       Date:  2016-03-31       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.